All results
1 results for smell loss and covid 19 study
-
Kinect-HD2
This is a Phase 3, open-label study to evaluate the long-term safety and tolerability of valbenazine, and to provide participants continued access to…
- Ages
- 18 Years - 75 Years
- Sexes
- All